Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
nH3vJNtSFDypBNWL
